Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Cristin McMurray

Anesthesiology Brookline, MA Medical Doctor

NPI 1215140215 CMS profile 483358

1 Brookline Pl Fl 1, Brookline, MA 02445

Open in the dashboard

General payments

$403

8 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Cristin McMurray of Brookline, MA is reported in the CMS Open Payments database as having received $403 across 8 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $24 1
2021 General $149 3
2020 General $181 3
2019 General $49 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cristin McMurray
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Cristin McMurray were reported at $0. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Cristin McMurray Anesthesiology median Middle half National median
2019 $49 $72 $23–$151 $163
2020 $181 $36 $17–$120 $114
2021 $149 $49 $21–$135 $132
2022 $0 $52 $22–$144 $149
2023 $0 $53 $23–$143 $160
2024 $24 $55 $25–$150 $164
2025 $0 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. SPR Therapeutics, Inc $149 1 payment
  2. Biohaven Pharmaceuticals, Inc. $103 1 payment
  3. Pfizer Inc. $56 3 payments
  4. Novartis Pharmaceuticals Corporation $49 1 payment
  5. Boston Scientific Corporation $26 1 payment
  6. Nevro Corp. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $403 8 payments
Products named General payments · program years 2019–2024
  1. SPRINT PNS System $149 1 payment
  2. NURTEC ODT Primary Care $103 1 payment
  3. GENERAL PAIN MANAGEMENT $26 1 payment
  4. NURTEC ODT Pain $24 1 payment
  5. ZAVZPRET $24 1 payment
  6. Omnia $20 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

539

Median for Pain Management: 951

Drug cost

$43,117

Median for Pain Management: $26,034

Branded share of claims

31%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 13 $17,560
Movantik Naloxegol Oxalate Brand 22 $8,970
Savella Milnacipran Hcl Brand 13 $6,355
Oxycodone Hcl Generic 77 $2,155
Morphine Sulfate Er Morphine Sulfate Brand 28 $1,916
Gabapentin Generic 121 $1,481
Celecoxib Generic 19 $1,216
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 74 $1,177
Pregabalin Generic 21 $587
Methadone Hcl Generic 19 $431

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$56,460

Of which drugs: $767

Medicare patients

264

Average age 71

Services billed

5,037

156 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 51%
Diabetes 24%
Depression 21%
Chronic kidney disease 18%
Osteoporosis 17%
Ischemic heart disease 12%
Cancer 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 43 4,543 $457
Injection, methylprednisolone acetate, 80 mg J1040 Office 25 29 $223
Injection, methylprednisolone acetate, 40 mg J1030 Office 15 19 $81

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NURTEC ODT
  • PFIZER INC. $12
$12 — —
ZAVZPRET
  • PFIZER INC. $12
$12 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

8 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record